ClearBridge Investments’s NovoCure NVCR Stock Holding History

ClearBridge Investments’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-79,923	Closed	-$3.32M	–	700
2023 Q2	$3.32M	Buy	79,923 +454	+0.6%	+$28.2K	﹤0.01%	573
2023 Q1	$4.78M	Buy	79,469 +1,491	+2%	+$119K	﹤0.01%	551
2022 Q4	$5.72M	Sell	77,978 -227	-0.3%	-$17.1K	0.01%	556
2022 Q3	$5.94M	Sell	78,205 -106	-0.1%	-$8.27K	0.01%	549
2022 Q2	$5.44M	Buy	78,311 +4,647	+6%	+$350K	0.01%	571
2022 Q1	$6.1M	Buy	+73,664	New	+$5.43M	﹤0.01%	588

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

ClearBridge Investments's NVCR Position: Q3 2023 in Review

ClearBridge Investments sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 79,923 shares — an estimated $3.32M sold.

ClearBridge Investments first reported a position in NVCR in Q1 2022 and held it in 6 quarters. The position peaked at $6.1M in Q1 2022. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

ClearBridge Investments reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
ClearBridge Investments sold 79,923 NovoCure shares in Q3 2023, an estimated $3.32M.
ClearBridge Investments first reported a position in NovoCure in Q1 2022 and held it in 6 quarters.
ClearBridge Investments's NovoCure position peaked at $6.1M in Q1 2022.
226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on ClearBridge Investments's 13F filing for Q3 2023, filed 13 Nov 2023.